Environmental triggers of dermatomyositis: a narrative review
- PMID: 33842655
- PMCID: PMC8033368
- DOI: 10.21037/atm-20-3719
Environmental triggers of dermatomyositis: a narrative review
Abstract
Dermatomyositis (DM) is an autoimmune disease that affects the skin, lungs, and muscle. Although the pathogenesis of DM is not completely understood, several environmental triggers have been linked to DM onset or flare. This article specifically examines the effects of herbal supplements, drugs, infections, ultraviolet (UV) radiation, and environmental pollutants on the onset or exacerbation of DM. Herbal supplements such as Spirulina platensis, Aphanizomenon flos-aquae, Chlorella, Echinacea, and Alfalfa have been implicated and are frequently used in health foods. Medications such as hydroxyurea, TNF-α inhibitors, immune checkpoint inhibitors (ICI), and penicillamine, as well as certain viral infections, such as parvovirus B19, coxsackie virus, polyomavirus, Epstein-Barr virus (EBV), hepatitis, influenza, and human immunodeficiency viruses (HIV) have been associated with DM onset. Bacterial infections and vaccinations have also been linked to the development of DM. Additional environmental factors, including UV radiation and air pollutants, such as silica, biological/mineral dust, and particulate air matter from vehicle and industrial emissions, may also play a role in DM pathogenesis. Overall, there is general agreement that an autoimmune attack of the skin, muscle, and lungs in DM can be triggered by various environmental factors and warrants further investigation.
Keywords: Dermatomyositis (DM); air pollution; drugs; herbal supplements; infections; triggers; ultraviolet irradiation (UV irradiation).
2021 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-3719). The series “Rheumatologic Skin Disease” was commissioned by the editorial office without any funding or sponsorship. VPW served as the unpaid Guest Editor of the series. VPW reports personal fees from EMD Serona, personal fees from Vielo, grants and personal fees from Pfizer, personal fees from Idera, personal fees from Octapharma, grants and personal fees from CSL Behring, grants from Corbus Pharmaceuticals, outside the submitted work; In addition, VPW has a patent CDASI with royalties paid. The authors have no other conflicts of interest to declare.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources